MicroRNA Biomarkers: Pitfalls and Potential.

IF 0.3 4区医学 Q4 ENGINEERING, BIOMEDICAL

IEEE Pulse Pub Date : 2023-05-01 DOI:10.1109/MPULS.2023.3294086

Mary Bates

引用次数: 0

Abstract

Thirty years ago, the small molecules we now know as microRNAs (miRNAs) would have been regarded as "junk" genetic material. Today, miRNAs have been hailed as promising biomarkers for diseases including cancer, neurological disorders, heart conditions, and infections. Although progress has been made toward characterizing the role of miRNAs in different diseases, there remain challenges in bringing them into clinical use. Researchers continue to explore where miRNAs will make the most impact.

查看原文本刊更多论文

微小核糖核酸生物标志物：陷阱和潜力。

30年前，我们现在所知的小分子微小RNA（miRNA）会被视为“垃圾”遗传物质。如今，miRNA已被誉为癌症、神经系统疾病、心脏病和感染等疾病的有前途的生物标志物。尽管在表征miRNA在不同疾病中的作用方面取得了进展，但将其应用于临床仍存在挑战。研究人员继续探索miRNA将在哪里产生最大影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

IEEE Pulse ENGINEERING, BIOMEDICAL-

CiteScore

1.10

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： IEEE Pulse covers both general and technical articles on current technologies and methods used in biomedical and clinical engineering; societal implications of medical technologies; current news items; book reviews; patent descriptions; and correspondence. Special interest departments, students, law, clinical engineering, ethics, new products, society news, historical features and government.